Technical Writer, Process Development

Job description:
 

We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment, and teamwork, and so can you.

We are currently recruiting for a Technical Writer join the Process Development team (PD). The purpose of this role is to collaborate with Scientists in the effective reporting of experimental data from work carried out within the PD department, to support the delivery of feasibility studies, Process Development, process scale up, technical transfer and process characterisation activities.

Oxford Biomedica’s Process Development team consists of experienced Scientists, Scientific Assistants, Engineers & Writers that have extensive expertise in all aspects of upstream and downstream development. PD take processes from the laboratory “bench” scale and apply process expertise and engineering fundamentals for delivery to Manufacturing.

Your responsibilities in this role would be:

• The authoring of clear and concise documentation including protocols and scientific reports to support Upstream and Downstream Process Development activities.
• Review documentation including protocols and technical reports prior to issue to clients.
• Produce and maintain technical report templates and outlines
• Maintain technical report writing procedures and guidelines.
• Function as department subject matter expert within Technical Writing, including training the team
• Maintain a high standard of record keeping and documentation so that information is clearly captured, disseminated, and reported.
• Disseminate critical findings which may have a business impact to other departments within the company.
• Maintain a high ethical standard and a commitment to producing high quality work.
• Ensure all scientific or proprietary data is submitted or recorded in appropriate official documentation.

We are looking for:

• A graduate or postgraduate degree (or equivalent level qualification) in a relevant science
• Previous operational experience within a Process development or GMP Manufacturing environment.
• Excellent experience using Microsoft word, PowerPoint and Excel
• A sound understanding of basic biopharmaceutical Process Development activities.
• Industry experience in authoring biopharma Process Development reports would be advantageous.
• A high standard or of written and verbal communication skills in English.
• The ability to collaborate cross departmentally to achieve PD departmental goals.
• Highly organised and the ability to manage multiple tasks & projects.
• Excellent organisational and time management skills

About Us:

Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

 What’s in it for you: 

• Highly competitive total reward packages 
• Wellbeing programmes 
• Development opportunities 
• Welcoming, friendly, supportive colleagues 
• A diverse and inclusive working environment 
• Our values are: Deliver Innovation, Be Inspiring and Have Integrity 
• State of the art laboratory and manufacturing facilities 

Collaborate. Contribute. Change lives.

Profile description:

We are looking for:

• A graduate or postgraduate degree (or equivalent level qualification) in a relevant science
• Previous operational experience within a Process development or GMP Manufacturing environment.
• Excellent experience using Microsoft word, PowerPoint and Excel
• A sound understanding of basic biopharmaceutical Process Development activities.
• Industry experience in authoring biopharma Process Development reports would be advantageous.
• A high standard or of written and verbal communication skills in English.
• The ability to collaborate cross departmentally to achieve PD departmental goals.
• Highly organised and the ability to manage multiple tasks & projects.
• Excellent organisational and time management skills

About Us:

Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

 What’s in it for you: 

• Highly competitive total reward packages 
• Wellbeing programmes 
• Development opportunities 
• Welcoming, friendly, supportive colleagues 
• A diverse and inclusive working environment 
• Our values are: Deliver Innovation, Be Inspiring and Have Integrity 
• State of the art laboratory and manufacturing facilities 

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.  

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).  

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.